Sep 30, 2019

Small cap healthcare stocks surge to billion-dollar plays

The Australian Financial Review mentioned that Starpharma was in a group of small cap biotech stocks in stage two trials that investors are closely in the next few years.

To read the full article, click here (paywall)

 This contains certain forward-looking statements.